Study survival and quality of life by follow-up time after stomach surgery
Part of Cancer, Digestive system clinical trials.
This study looks at how long people with stage II or III stomach (gastric) cancer tend to live and how their day-to-day well-being changes over different follow-up times after surgery. It may help doctors understand the best follow-up schedule to support recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older
- You had surgery for stomach (gastric) cancer that was stage II or stage III
- A doctor confirmed your stage using the AJCC 8th system (your clinic can explain your report)
- You can understand the study details and freely choose to join
- You are not pregnant and do not have an intellectual disability that prevents informed consent
- You can safely get CT scans (no severe kidney problems and no major side effects that prevent CT)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different types of follow-up care after total stomach removal surgery for advanced stomach cancer. It aims to see if a more intensive follow-up plan helps patients live longer or feel better than the usual check-ups.
This study looks at how often people who had surgery for esophageal or stomach cancer should have follow-up tests. It aims to find the best way to monitor you after treatment.
This study monitors people after surgery for gastric cancer. It checks how patients recover and helps doctors learn more about the condition. You can join if you have stomach discomfort and are receiving care at the gastric surgery clinic of this center.
This study tests whether “pre-rehabilitation” (getting you stronger before treatment) improves outcomes for people with stage II–III stomach cancer who are planning chemo and immunotherapy before surgery. It may help your body handle treatment and surgery more safely.
This trial is for people who have already had chemotherapy and surgery for stomach cancer. It compares different follow-up approaches to see if skipping more chemo after surgery is safe and effective.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.